|
|
M Sata, M Ikebe
J Clin Invest. 1996;
98(12):2866
doi:10.1172/JCI119115
Abstract |
Full text
| PDF

M
ore than 30 missense mutations in the beta-cardiac myosin heavy chain gene have been shown to be responsible for familial hypertrophic cardiomyopathy. To clarify the effects of these point mutations on myosin motor function, we expressed wild-type and mutant human beta-cardiac myosin heavy chains in insect cells with human cardiac light chains. The wild-type myosin was well purified with similar enzymatic and motor activities to those of the naturally isolated V3 cardiac myosin. Arg249-->Gln and Arg453-->Cys mutations resulted in decreased actin translocating activity (61 and 23% of the wild-type, respectively) with decreased intrinsic ATPase activity. Arg403-->Gln mutation greatly decreased actin translocating activity (27% of wild type) with a 3.3-fold increased dissociation constant for actin, while intrinsic ATPase activity was unchanged. Val606-->Met mutation only mildly affected the actin translocating activity as well as ATPase activity of myosin. The degree of deterioration by each mutation was closely correlated with the prognosis of the affected kindreds, indicating that myosin dysfunction caused by the point mutations is responsible for the pathogenesis of the disease. Structure/function relationship of myosin is discussed.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(25)
| Title and authors |
Publication |
Year |
How Do Mutations in Contractile Proteins Cause the Primary Familial Cardiomyopathies?
Steven B. Marston
|
J. of Cardiovasc. Trans. Res.
|
2011 |
Mechanisms of disease: hypertrophic cardiomyopathy
Norbert Frey, Mark Luedde, Hugo A. Katus
|
Nat Rev Cardiol
|
2011 |
Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.
Marco L Alves, Robert D Gaffin, Beata M Wolska
|
Journal of Molecular and Cellular Cardiology
|
2010 |
Hypertrophic cardiomyopathy: from genetics to treatment
Ali J. Marian
|
European Journal of Clinical Investigation
|
2010 |
Diastolic Myocardial Mechanics in Hypertrophic Cardiomyopathy
Shemy Carasso, Hua Yang, Anna Woo, Michal Jamorski, E. Douglas Wigle, Harry Rakowski
|
Journal of the American Society of Echocardiography
|
2010 |
Mechanical and Energetic Consequences of HCM-Causing Mutations
Cecilia Ferrantini, Alexandra Belus, Nicoletta Piroddi, Beatrice Scellini, Chiara Tesi, Corrado Poggesi
|
J. of Cardiovasc. Trans. Res.
|
2009 |
Experimental therapies in hypertrophic cardiomyopathy.
Ali J Marian
|
J. of Cardiovasc. Trans. Res.
|
2009 |
Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy
Mark Luedde, Ulrich Flögel, Maike Knorr, Christina Grundt, Hans-Joerg Hippe, Benedikt Brors, Derk Frank, Uta Haselmann, Claude Antony, Mirko Voelkers, Juergen Schrader, Patrick Most, Bjoern Lemmer, Hugo A. Katus, Norbert Frey
|
J Mol Med
|
2009 |
Protein Science Encyclopedia
John P. Konhilas, Leslie A. Leinwand
|
Protein Science Encyclopedia
|
2008 |
Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle
Homa Tajsharghi, Ing-Marie Fyhr
|
Scand Cardiovasc J
|
2008 |
|